“Global Ophthalmic Equipment market set to grow to $75bn by 2024” says new Visiongain report

03 June 2019
Pharma

Visiongain has published a new pharma report The Ophthalmic Equipment Market Forecast 2019-2029: Vision Care Products, Ophthalmology Surgical Devices, Diagnostic and Monitoring Devices, Consumers, Hospitals, Specialty Clinics and Ambulatory Surgery Centres.

The ophthalmic equipment market is estimated to have reached $51 bn in 2018 and is expected to grow at a CAGR of 7.4% during the forecast period. In 2019, Vision Care Products segment held the biggest market share in the ophthalmic equipment market.

This report profiled the selected companies: Alcon, BAUSCH + LOMB Incorporated, Carl Zeiss Meditec AG, Essilor International S.A., Johnson & Johnson Vision, NIDEK CO., LTD., STAAR Surgical Company, Ziemer Ophthalmic Systems AG and others.

The lead analyst commented that "There is a growing demand for ophthalmic equipment such as vision care products and ophthalmology surgical devices, mainly due to the increasing incidence of myopia across the world. As the myopic population increases globally, it provides opportunity for manufacturers of intraocular lenses to expand their market volume in ophthalmology market. Approval of new technology for correction of myopia would further enhance the opportunity for capitalization.

Rapid rise in the geriatric population across the globe, technological advancements in ophthalmic devices for improving the diagnosis and treatment, increasing adoption of digital devices globally are some of the factors which are expected to drive the growth of ophthalmic equipment market during the forecast period."

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

Read

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

Read

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

Read

Visiongain Publishes Advanced Therapy Medicinal Products (ATMP) Market Report 2021-2031

Currently, the ATMP market is at a nascent stage and is expected to flourish during near future owing to increasing research and development activities and rising use of ATMP therapy products in treatment areas with low or no alternative treatment options support the market growth

24 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever